DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Brandse JF, Wildenberg M, de Bruyn JR et al.
Fecal Loss of Infliximab as a Cause of Lack of Response in Severe Inflammatory Bowel Disease.
Gastroenterology 2013;
144 (Suppl. 01) 36
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.